Experimental
Fermentation and Isolation Fermentation conditions and isolation of the crude material were as described1). The orange material mainly consisting of sarubicin A was chromatographed on a silica gel column (KH2PO4-buffered silica gel, 30 x 3 cm). Elution was with ethyl acetate. Sarubicin B was the first yellow band which was clearly separated from other red and yellow minor bands and the main red component sarubicin A. The corresponding fractions obtained from several columns containing sarubicin B were combined and concentrated to a small volume. The antibiotic precipitated as an orange crystalline substance.
Mass Spectroscopy
Mass spectra were recorded on a JEOL JMS-D 100 spectrometer at 75 eV, direct inlet system, heated at 160°C. Exact mass measurements were performed using the peak matching method (PFK as standard).
Antibacterial Activity
The minimum inhibitory concentrations (MIC) of the antibiotic were determined for various bacteria by the agar plate diffusion method. Samples of sarubicin B were dissolved in DMSO and diluted with methanol to the final concentration. (Fig. 1) shows a molecular ion at m/z 258.
Results

Physical and Chemical Properties
The accurate mass measurement for this peak gave a value of 258.0625 indicating a molecular formula of C13HION2O4 (Calcd. 258.0640). The ultraviolet absorption spectrum of sarubicin B in methanol has maxima at 232, 275, 349 and 434
nm. Fig. 2 shows the infrared absorption spectrum of sarubicin B (KBr). The spectrum shows characteristic absorptions at 3355 and 3170 cm-1 (-NH.) and at 1712, 1645, 1600 and 1545 cm-1 (C=O, quinone, -CONH2). Structural elucidation studies of sarubicin B, details of which will be published elsewhere3), have indicated that the antibiotic has structure as shown Fig. 3 . 
